<DOC>
	<DOCNO>NCT02268448</DOCNO>
	<brief_summary>The purpose study assess safety efficacy oral clonidine subject symptomatic atopic dermatitis ass safety efficacy oral naltrexone subject symptomatic atopic dermatitis .</brief_summary>
	<brief_title>Atopic Dermatitis Itch</brief_title>
	<detailed_description>This study serve pilot study determine efficacy safety two novel oral agent ( clonidine , naltrexone ) treatment chronic , non-experimentally induced itch atopic dermatitis . In study , eight subject symptomatic atopic dermatitis recruit treat either oral clonidine ( four subject ) oral naltrexone ( four subject ) . Disease burden evaluate 4 week treatment report subjective symptomatology via surveys/questionnaire , neurometer study , clinical assessment .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Clonidine</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>1 . Age range 1840 year old ability give inform consent HIPAA authorization . 2 . Female subject childbearing potential must negative pregnancy test , must agree practice two method effective birth control study period clonidine FDA pregnancy category C drug ( include abstinence , oral implant contraceptive condom ) . 3 . Diagnosis AD via simplify UK Working Group Criteria baseline PSGA score 2 great 4 . Willingness adhere study protocol 1 . Use topical antiinflammatory medication 2 week oral antiinflammatory medication 4 week prior study start 2 . Use chronic pain medication ( include opioids , antidepressant antiepileptic drug ) 3 . History radiation chemotherapy 4 . History traumatic injury perspective test sit 5 . Use hormonereplacement medication within six week prior study start avoid confound influence sensory pain perception ( Fillingim &amp; Edwards , 2001 ) . 6 . Unstable thyroid function exclude thyroid relate neuropathy ( Duyff et al , 2000 ) 7 . Known history central peripheral nervous system dysfunction 8 . History acute hepatitis , chronic liver disease end stage liver disease 9 . History human immunodeficiency virus ( HIV ) acquire immune deficiency syndrome 10 . History neuropathy associate chronic obstructive pulmonary disease , diabetes mellitus , document exposure organophosphates heavy metal ( polychlorinated biphenyls ) 11 . Known nutritional deficiency ( vitamin B12 , vitamin D , iron zinc ) within 3 month prior study start 12 . Illicit drug use 13 . History daily use power tool 14 . Lyme disease , porphyria , rheumatoid arthritis , Hansen 's disease ( leprosy ) use antineoplastic chemotherapeutic agent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>itch atopic dermatitis</keyword>
</DOC>